Leanne Lanieri
Impact in
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 14
- HER2/EGFR in Cancer Research 11
- CAR-T cell therapy research 3
-
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- Jose F. Ponte (12 shared papers)Jan Pinkas (5 shared papers)Jennifer A. Coccia (6 shared papers)Olga Ab (7 shared papers)Laura M. Bartle (3 shared papers)Rodrigo Ruiz‐Soto (1 shared paper)Yinghui Zhou (1 shared paper)Ravi Chari (7 shared papers)
- Journals
- Blood (6 papers)Cancer Research (4 papers)Molecular Cancer Therapeutics (3 papers)Neoplasia (2 papers)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Leanne Lanieri
16 papers receiving 298 citations
Peers
Comparison fields: 5 of 47
- Oncology 183
- Radiology, Nuclear Medicine and Imaging 140
- Reproductive Medicine 25
- Pathology and Forensic Medicine 37
- Genetics 18
Countries citing papers authored by Leanne Lanieri
This map shows the geographic impact of Leanne Lanieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leanne Lanieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leanne Lanieri more than expected).
Fields of papers citing papers by Leanne Lanieri
This network shows the impact of papers produced by Leanne Lanieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leanne Lanieri. The network helps show where Leanne Lanieri may publish in the future.
Co-authors
The 25 scholars most cited alongside Leanne Lanieri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 98 | |
| 2 | 2016 | 68 | |
| 3 | 2020 | 30 | |
| 4 | 2017 | 28 | |
| 5 | 2022 | 24 | |
| 6 | 2019 | 19 | |
| 7 | 2020 | 11 | |
| 8 | 2020 | 6 | |
| 9 | 2017 | 6 | |
| 10 | 2019 | 5 | |
| 11 | 2015 | 3 | |
| 12 | 2014 | 3 | |
| 13 | 2015 | 2 | |
| 14 | 2023 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2017 | 1 | |
| 17 | 2017 | 1 | |
| 18 | 2026 | 0 | |
| 19 | 2013 | 0 |
About Leanne Lanieri
Leanne Lanieri is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Hematology and Immunology, having authored 19 papers that have together received 307 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Ovarian cancer diagnosis and treatment (3 papers), Advanced Breast Cancer Therapies (3 papers), CAR-T cell therapy research (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Cancer therapeutics and mechanisms (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Oncology (183 citations), Radiology, Nuclear Medicine and Imaging (140 citations), Reproductive Medicine (25 citations), Pathology and Forensic Medicine (37 citations) and Genetics (18 citations). Leanne Lanieri has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Jose F. Ponte, Jan Pinkas, Jennifer A. Coccia, Olga Ab, Laura M. Bartle, Rodrigo Ruiz‐Soto, Yinghui Zhou, Ravi Chari, Thomas A. Keating and Wayne C. Widdison. Their work appears in journals such as Blood, Cancer Research, Molecular Cancer Therapeutics, Neoplasia and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.